NALIA Systems provides sensitive and qualitative multiplex immunoassays. It designs and produces customised biomarker panels for use in clinical trials and in biomedical research. These provide massive improvements in productivity and reduce the amount of sample needed. In addition, NALIA’s technology enables the provision of rapid, laboratory-standard multiplex immunoassays at the point of care for the first time. The company is developing prototype cartridges and readers.